Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CP✓SelectedUSD · CPGSK vs CP performance historyLatest closeAs of-1.23%11/11
Stock and ETF performance explorer

GSK vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.9%
CP return
+251.7%
Excess return
-148.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D-1.2%0.0%-1.2%-1.2%
7D-1.1%-0.7%-0.4%-0.9%
30D+7.8%+9.6%-1.8%+5.0%
3M+0.3%+2.2%-1.9%-0.4%
6M+3.4%+11.1%-7.7%+0.2%
YTD+5.9%+28.2%-22.3%-1.6%
1Y+8.2%+32.2%-23.9%-0.4%
3Y+65.3%+35.5%+29.8%+49.1%
5Y+43.3%+26.8%+16.5%+29.5%
10Y+102.9%+256.9%-154.0%+38.9%
All+102.9%+251.7%-148.8%+38.9%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling